Latest News & Features
Americas
The US District Court for the Northern District of California decided yesterday, August 11, that Gilead should be entitled to attorneys’ fees following a lawsuit in which Merck was found guilty of misconduct. 12 August 2016
Africa
Roche has defeated a cybersquatter in a dispute centring on 18 domain names that infringed trademarks owned by the pharmaceutical company. 11 August 2016
Big Pharma
Pharming Group, a Netherlands based company, has agreed to buy the North American commercialisation rights to its drug Ruconest from Valeant Pharmaceuticals. 11 August 2016
Asia
Even if India moves towards a patent-unfriendly environment for green technologies, the pro-patent and pro-environment lobbies can coexist and meet their respective goals, argue Swarup Kumar and Jitesh Kumar of Remfry & Sagar. 11 August 2016
Americas
Amgen has entered into a global agreement with Advaxis, allowing for the development and commercialisation of ADXS-NEO, a preclinical cancer immunotherapy treatment. 10 August 2016
Americas
Teva has settled a dispute with 48 US states after it was found guilty of attempting to pursue ‘pay-for-delay’ agreements with generic drug makers. 10 August 2016
Americas
Shionogi and Concordia Pharmaceuticals sued Hi-Tech Pharmacal yesterday for allegedly infringing patents centring on the drug Ulesfia, an anti-parasite medication. 9 August 2016
Americas
NuScience, a US based nutritional supplement company, has asked a court to imprison two brothers who are at the centre of a trade secrets lawsuit. 9 August 2016
Americas
The US and China take very different approaches to the patentability of a range of inventions in the life sciences field, as Yu Guo of China Patent Agent reports. 9 August 2016
Americas
AstraZeneca has sued Mylan for allegedly infringing its patents covering the drug Faslodex. 8 August 2016